Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MONGOUE-TCHOKOTE, Solange")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

New statistical software for the proportional hazards model with current status dataMONGOUE-TCHOKOTE, Solange; KIM, Jong-Sung.Computational statistics & data analysis. 2008, Vol 52, Num 9, pp 4272-4286, issn 0167-9473, 15 p.Article

Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancerJANOFF, Daniel M; PETERSON, Chad; MONGOUE-TCHOKOTE, Solange et al.BJU international (Papier). 2005, Vol 96, Num 4, pp 503-507, issn 1464-4096, 5 p.Article

Improving Colorectal Cancer Screening in Asian AmericansCARNEY, Patricia A; LEE-LIN, Frances; MONGOUE-TCHOKOTE, Solange et al.Cancer. 2014, Vol 120, Num 11, pp 1702-1712, issn 0008-543X, 11 p.Article

Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsySPURGEON, Stephen E. F; MONGOUE-TCHOKOTE, Solange; COLLINS, Lauren et al.Urology (Ridgewood, NJ). 2007, Vol 69, Num 5, pp 931-935, issn 0090-4295, 5 p.Article

Recursive partitioning for risk stratification in men undergoing repeat prostate biopsiesGARZOTTO, Mark; PARK, Yon; MONGOUE-TCHOKOTE, Solange et al.Cancer. 2005, Vol 104, Num 9, pp 1911-1917, issn 0008-543X, 7 p.Article

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory resultsPRINS, Renee C; RADEMACHER, Brooks L; MONGOUE-TCHOKOTE, Solange et al.Urologic oncology. 2012, Vol 30, Num 1, pp 33-37, issn 1078-1439, 5 p.Article

A multilevel approach to predicting community addiction treatment attitudes about contingency managementHARTZLER, Bryan; DONOVAN, Dennis M; TILLOTSON, Carrie J et al.Journal of substance abuse treatment. 2012, Vol 42, Num 2, pp 213-221, issn 0740-5472, 9 p.Article

BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CMLPRESS, Richard D; LOVE, Zac; TRONNES, Ashlie A et al.Blood. 2006, Vol 107, Num 11, pp 4250-4256, issn 0006-4971, 7 p.Article

  • Page / 1